Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,546 | 264 | 99.5% |
| Education | $39.16 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,310 | 51 | $0 (2024) |
| Amgen Inc. | $967.63 | 27 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $400.90 | 20 | $0 (2021) |
| Genentech USA, Inc. | $400.16 | 42 | $0 (2022) |
| Optinose US, Inc. | $341.81 | 20 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $318.12 | 9 | $0 (2022) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $258.00 | 15 | $0 (2021) |
| UPSHER-SMITH LABORATORIES LLC | $225.93 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $211.98 | 9 | $0 (2024) |
| PFIZER INC. | $196.39 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $952.42 | 16 | AstraZeneca Pharmaceuticals LP ($638.14) |
| 2023 | $767.49 | 12 | AstraZeneca Pharmaceuticals LP ($653.48) |
| 2022 | $1,561 | 32 | AstraZeneca Pharmaceuticals LP ($851.21) |
| 2021 | $1,690 | 91 | Biohaven Pharmaceuticals, Inc. ($400.90) |
| 2020 | $888.96 | 49 | OptiNose US, Inc. ($269.53) |
| 2019 | $780.35 | 30 | Amgen Inc. ($329.90) |
| 2018 | $443.94 | 14 | Amgen Inc. ($212.85) |
| 2017 | $502.20 | 22 | AstraZeneca Pharmaceuticals LP ($259.08) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: PAIN | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Bioventus LLC | EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: DEVICES | ||||||
| 10/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: PAIN | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $108.37 | General |
| Category: Respiratory | ||||||
| 06/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: PAIN | ||||||
| 06/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $122.05 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Respiratory | ||||||
| 02/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: PAIN | ||||||
| 02/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: PAIN | ||||||
| 01/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA, FASENRA | Food and Beverage | In-kind items and services | $367.65 | General |
| Category: Respiratory | ||||||
| 12/04/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Central Nervous System | ||||||
| 10/26/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PAIN | ||||||
| 09/26/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $19.11 | General |
| 09/15/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 08/18/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PAIN | ||||||
| 07/25/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2023 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,474 | 13,239 | $704,908 | $118,452 |
| 2022 | 17 | 2,511 | 12,164 | $552,805 | $125,539 |
| 2021 | 16 | 2,409 | 10,369 | $501,302 | $123,786 |
| 2020 | 16 | 2,055 | 8,979 | $431,857 | $96,552 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 505 | 1,175 | $336,146 | $65,863 | 19.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 292 | 2,482 | $44,521 | $12,404 | 27.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 231 | 322 | $43,836 | $8,882 | 20.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 16 | 692 | $27,680 | $7,386 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 365 | 719 | $57,701 | $6,578 | 11.4% |
| 76380 | Limited or follow-up ct scan | Office | 2023 | 38 | 41 | $16,705 | $3,649 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $16,166 | $3,293 | 20.4% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 32 | 32 | $18,541 | $2,594 | 14.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 19 | 19 | $9,750 | $2,402 | 24.6% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 69 | 96 | $8,973 | $1,814 | 20.2% |
| 92553 | Test for hearing various pitches using earphone and device placed against the bone | Office | 2023 | 46 | 51 | $5,996 | $1,433 | 23.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 222 | 1,703 | $19,490 | $653.40 | 3.4% |
| 92567 | Test to assess middle ear function | Office | 2023 | 48 | 52 | $2,686 | $584.16 | 21.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 244 | 1,610 | $62,450 | $562.58 | 0.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 293 | 4,191 | $34,267 | $354.50 | 1.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 522 | 1,198 | $256,372 | $68,503 | 26.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 285 | 2,403 | $31,239 | $10,563 | 33.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 235 | 332 | $40,504 | $9,690 | 23.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 346 | 652 | $42,380 | $6,066 | 14.3% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 17 | 483 | $19,320 | $5,239 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 76 | 76 | $19,988 | $5,077 | 25.4% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 52 | 52 | $26,416 | $4,907 | 18.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 32 | 35 | $17,149 | $4,523 | 26.4% |
| 76380 | Limited or follow-up ct scan | Office | 2022 | 29 | 34 | $11,900 | $3,025 | 25.4% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 60 | 94 | $7,238 | $1,980 | 27.4% |
About Dr. Wallace Duff, M.D
Dr. Wallace Duff, M.D is a Otolaryngology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467446799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wallace Duff, M.D has received a total of $7,586 in payments from pharmaceutical and medical device companies, with $952.42 received in 2024. These payments were reported across 266 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,546).
As a Medicare-enrolled provider, Duff has provided services to 9,449 Medicare beneficiaries, totaling 44,751 services with total Medicare billing of $464,330. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Specialist
- Location Omaha, NE
- Active Since 09/01/2005
- Last Updated 01/18/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467446799
Products in Payments
- BREZTRI (Drug) $1,141
- Aimovig (Biological) $921.05
- NURTEC ODT (Drug) $792.51
- SYMBICORT (Drug) $694.72
- BEVESPI AEROSPHERE (Drug) $557.79
- FARXIGA (Drug) $456.39
- Xofluza (Drug) $400.16
- FASENRA (Biological) $347.65
- Xhance (Drug) $341.81
- AIMOVIG (Biological) $238.09
- AJOVY (Biological) $155.77
- VOQUEZNA (Drug) $124.90
- UBRELVY (Drug) $123.46
- TOSYMRA (Drug) $105.20
- ZAVZPRET (Drug) $95.40
- REYVOW (Drug) $93.60
- ZEMBRACE SYMTOUCH (Drug) $67.31
- EMGALITY (Drug) $64.91
- BOTOX CHRONIC MIGRAINE (Drug) $63.42
- BREZTRI AEROSPHERE (Drug) $56.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Omaha
Perry Johnson, Md, MD
Otolaryngology — Payments: $25,214
Rahul Varman, Md, MD
Otolaryngology — Payments: $11,663
Stanley Schack, M.d, M.D
Otolaryngology — Payments: $6,131
Dr. Eugene Son, M.d, M.D
Otolaryngology — Payments: $5,173
Jacob Bailey
Otolaryngology — Payments: $4,760
Jessica Moran-Hansen, M.d, M.D
Otolaryngology — Payments: $4,515